MDRNA Repays $5.5M Loan to GE Capital

The repayment marks the company's latest move toward overcoming financial woes that have persisted since it was created last summer out of now-defunct nasal drug-delivery shop Nastech Pharmaceutical

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.